The myotonic dystrophy type 2 (DM2) CCTG expansion does not reduce ZNF9 transcript levels or prevent splicing.

被引:0
|
作者
Ranum, LPW [1 ]
Moseley, ML [1 ]
Jin, DD [1 ]
Liquori, CL [1 ]
Day, JW [1 ]
机构
[1] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
1946
引用
收藏
页码:502 / 502
页数:1
相关论文
共 50 条
  • [31] Differences in distribution and type of myotonic discharges in genetically confirmed myotonic dystrophy type 1 (DM1) versus type 2 (DM2)
    Logigian, E
    Ciafaloni, E
    Quinn, C
    Dilek, N
    Moxley, R
    Thornton, C
    [J]. NEUROLOGY, 2006, 66 (05) : A320 - A320
  • [32] Detailed analysis of the unstable region of the ZNF9 gene causing DM2/PROMM in normal chromosomes.
    Baiget, M
    Martorell, L
    Cusco, I
    Calaf, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 564 - 564
  • [33] A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2
    Bonifazi, E
    Vallo, L
    Giardina, E
    Botta, A
    Novelli, G
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2004, 13 (03) : 164 - 166
  • [34] Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1)
    Vihola, A.
    Sirito, M.
    Bachinski, L.
    Olufemi, S.
    Raheem, O.
    Suominen, T.
    Udd, B.
    Krahe, R.
    [J]. NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 858 - 858
  • [35] Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)
    Gaul, C.
    Schmidt, T.
    Windisch, G.
    Wieser, T.
    Mueller, T.
    Vielhaber, S.
    Zierz, S.
    Leplow, B.
    [J]. NEUROLOGY, 2006, 67 (02) : 350 - 352
  • [36] Sub-Regional Body Composition and Clinical Endpoints in Myotonic Dystrophy Type 2 (DM2)
    Puwanant, Araya
    Isfort, Michael C.
    Kelleher, Annmarie
    Brown, Kathryn
    Su, Xiaowei William
    Clemens, Paula R.
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S116 - S116
  • [37] Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2)
    Kress, W
    Mueller-Myhsok, B
    Ricker, K
    Schneider, C
    Koch, MC
    Toyka, KV
    Mueller, CR
    Grimm, T
    [J]. NEUROMUSCULAR DISORDERS, 2000, 10 (07) : 478 - 480
  • [38] Progressive frontal lobe impairment in myotonic dystrophy type 1 (DM1) and type 2 (DM2): A longitudinal study
    Meola, G
    Sansone, V
    Gandossini, S
    Milanese, SD
    Cattaneo, E
    Brescia, A
    Cotticelli, B
    Zanetti, O
    Calabria, M
    Cotelli, M
    Binetti, G
    [J]. NEUROLOGY, 2005, 64 (06) : A415 - A415
  • [39] Alternative splicing alterations of Ca2+handling genes are associated with Ca2+signal dysregulation in myotonic dystrophy type 1 ( DM1) and type 2 ( DM2) myotubes
    Santoro, M.
    Piacentini, R.
    Masciullo, M.
    Bianchi, M. L. E.
    Modoni, A.
    Podda, M. V.
    Ricci, E.
    Silvestri, G.
    Grassi, C.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (04) : 464 - 476
  • [40] The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): Long-term outcomes
    Sansone, V. A.
    Brigonzi, E.
    Schoser, B.
    Villani, S.
    Gaeta, M.
    De Ambroggi, G.
    Bandera, F.
    De Ambroggi, L.
    Meola, G.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1147 - 1153